Physiol. Genomics Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics 32: 128-141, 2007. First published October 2, 2007; doi:10.1152/physiolgenomics.00108.2007
1094-8341/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
32/1/128    most recent
00108.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boucherat, O.
Right arrow Articles by Bourbon, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boucherat, O.
Right arrow Articles by Bourbon, J. R.
Received 11 May 2007; accepted in final form 26 September 2007.
Physiological Genomics 32:128-141 (2008)
1094-8341/07 $8.00 © 2008 American Physiological Society

Gene expression profiling in lung fibroblasts reveals new players in alveolarization

Olivier Boucherat 1,2, Marie-Laure Franco-Montoya 1,2, Christelle Thibault 3, Roberto Incitti 4, Bernadette Chailley-Heu 1,2, Christophe Delacourt 1,2 and Jacques R. Bourbon 1,2

1 Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 841, Institut Mondor de Recherche Biomédicale (IMRB), Département de Biologie et Thérapeutiques Cardiorespiratoires et Hépatiques
2 IFR10, Faculté de Médecine, Université Paris 12, Créteil
3 Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch
4 IFR10, Plate-forme de Génomique, INSERM, Hôpital Henri Mondor, Créteil, France

Little is known about the molecular basis of lung alveolarization. We used a microarray profiling strategy to identify novel genes that may regulate the secondary septation process. Rat lung fibroblasts were extemporaneously isolated on postnatal days 2, 7, and 21, i.e., before, during, and after septation, respectively. Total RNA was extracted, and cRNAs were hybridized to Affymetrix rat genome 230 2.0 microarrays. Expression levels of a selection of genes were confirmed by real-time PCR. In addition to genes already known to be upregulated during alveolarization including drebrin, midkine, Fgfr3, and Fgfr4, the study allowed us to identify two remarkable groups of genes with opposite profiles, i.e., gathering genes either transiently up- or downregulated on day 7. The former group includes the transcription factors retinoic acid receptor (RXR)-{gamma} and homeobox (Hox) a2, a4, and a5 and genes involved in Wnt signaling (Wnt5a, Fzd1, and Ndp); the latter group includes the extracellular matrix components Comp and Opn and the signal molecule Slfn4. Profiling in whole lung from fetal life to adulthood confirmed that changes were specific for alveolarization. Two treatments that arrest septation, hyperoxia and dexamethasone, inhibited the expression of genes that are upregulated during alveolarization and conversely enhanced that of genes weakly expressed during alveolarization and upregulated thereafter. The possible roles of these genes in secondary septation are discussed. Gene expression profiling analysis on freshly isolated cells represents a powerful approach to provide new information about differential regulation of genes during alveolarization and pathways potentially involved in the pathogenesis of bronchopulmonary dysplasia.

bronchopulmonary dysplasia; hyperoxia; Hox; Wnt; Opn







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.